Caner Saygin: How TP53-mutant CH progresses during myeloma therapy

Caner Saygin, Leukemologist at The University of Chicago, shared a post on X:

“Jen Cooperrider presenting cool data on how TP53-mutant CH progresses during myeloma therapy.

So proud of our team! ”